NCT01364558View on ClinicalTrials.gov

A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Epilepsy
Interventions
DRUG

Diazepam

Diazepam will be administered as a 5 mg dose given IV. The two nasal formulations will be given as a 10 mg dose.

DRUG

Diazepam

IV diazepam will be given as a 5 mg dose. The two nasal formulations will be given as 10 mg doses.

Trial Locations (1)

55114

Prism Clinical Research Unit, Saint Paul

Sponsors

Collaborators (1)

Neurelis, Inc.
All Listed Sponsors
collaborator

Neurelis, Inc.

INDUSTRY

lead

University of Minnesota

OTHER

NCT01364558 - A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers | Biotech Hunter | Biotech Hunter